These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16550720

  • 1. Acromegaly: effects on bone metabolism and mass.
    Bogazzi F, Cosci C, Sardella C, Martino E, Gasperi M.
    J Endocrinol Invest; 2005; 28(10 Suppl):33-5. PubMed ID: 16550720
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.
    Tütüncü NB, Erbaş T.
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):328-32. PubMed ID: 15216451
    [Abstract] [Full Text] [Related]

  • 3. Rheumatologic and skeletal changes in acromegaly.
    Lieberman SA, Björkengren AG, Hoffman AR.
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):615-31. PubMed ID: 1521515
    [Abstract] [Full Text] [Related]

  • 4. Somatopause: dismetabolic and bone effects.
    Lombardi G, Tauchmanova L, Di Somma C, Musella T, Rota F, Savanelli MC, Colao A.
    J Endocrinol Invest; 2005 Sep; 28(10 Suppl):36-42. PubMed ID: 16550721
    [Abstract] [Full Text] [Related]

  • 5. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W, Kochman M, Misiorowski W, Zdunowski P.
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [Abstract] [Full Text] [Related]

  • 6. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study.
    Battista C, Chiodini I, Muscarella S, Guglielmi G, Mascia ML, Carnevale V, Scillitani A.
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):378-82. PubMed ID: 18616713
    [Abstract] [Full Text] [Related]

  • 7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 8. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [Abstract] [Full Text] [Related]

  • 9. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A, Terzolo M, Bondanelli M, Galderisi M, Vitale G, Reimondo G, Ambrosio MR, Pivonello R, Lombardi G, Angeli A, degli Uberti EC.
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [Abstract] [Full Text] [Related]

  • 10. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
    Madeira M, Neto LV, de Lima GA, Moreira RO, de Mendonça LM, Gadelha MR, Farias ML.
    Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
    [Abstract] [Full Text] [Related]

  • 11. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
    Bielohuby M, Roemmler J, Manolopoulou J, Johnsen I, Sawitzky M, Schopohl J, Reincke M, Wolf E, Hoeflich A, Bidlingmaier M.
    Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373
    [Abstract] [Full Text] [Related]

  • 12. Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly.
    Jockenhövel F, Rohrbach S, Deggerich S, Reinwein D, Reiners C.
    Eur J Med Res; 1996 May 24; 1(8):377-82. PubMed ID: 9360937
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F.
    Growth Horm IGF Res; 2009 Feb 24; 19(1):24-30. PubMed ID: 18567522
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.
    Bolanowski M, Daroszewski J, Medraś M, Zadrozna-Sliwka B.
    J Bone Miner Metab; 2006 Feb 24; 24(1):72-8. PubMed ID: 16369902
    [Abstract] [Full Text] [Related]

  • 15. Regulation of bone mass by growth hormone.
    Olney RC.
    Med Pediatr Oncol; 2003 Sep 24; 41(3):228-34. PubMed ID: 12868124
    [Abstract] [Full Text] [Related]

  • 16. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P, Zwimpfer C, Zapf J, Schmid C.
    Acta Obstet Gynecol Scand; 2006 Sep 24; 85(8):900-5. PubMed ID: 16862465
    [Abstract] [Full Text] [Related]

  • 17. The role for growth hormone in linking arthritis, osteoporosis, and body composition.
    Tauchmanova L, Di Somma C, Rusciano A, Lombardi G, Colao A.
    J Endocrinol Invest; 2007 Sep 24; 30(6 Suppl):35-41. PubMed ID: 17721072
    [Abstract] [Full Text] [Related]

  • 18. Biochemical evidence supporting the Cortina criteria.
    von Werder K.
    J Endocrinol Invest; 2005 Sep 24; 28(11 Suppl International):81-3. PubMed ID: 16625853
    [Abstract] [Full Text] [Related]

  • 19. Circulating cytokines in relation to bone mineral density changes in patients with acromegaly.
    Bolanowski M, Daroszewski J, Zatonska K, Arkowska A.
    Neuro Endocrinol Lett; 2006 Sep 24; 27(1-2):183-8. PubMed ID: 16648806
    [Abstract] [Full Text] [Related]

  • 20. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug 24; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.